IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

Children with bronchopulmonary dysplasia belong to the risk group of severe respiratory-syncytial viral infection (RSV). World experience and authors' own clinical data show that seasonal immunoprophylaxis of RSV infection's severe course by palivizumab in these patients allows reducing frequency of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	A. A. Baranov, I. V. Davydova, T. V. Turti, L. S. Namazova-Baranova, V. V. Altunin, E. P. Zimina, E. V. Pavlyukova
Formato:	Artigo
Idioma:	Russo
Publicado em:	Union of pediatricians of Russia 2012-12-01
coleção:	Педиатрическая фармакология
Assuntos:	respiratory-syncytial virus bronchopulmonary dysplasia acute respiratory viral infection respiratory function palivizumab
Acesso em linha:	https://www.pedpharma.ru/jour/article/view/268
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!